KA

Kumar Akshay Verma

Active Director Additional Director DIN 08536483
DIN 08536483 First appointment Aug 2019 Primary industry Veterinary
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2019
Shareholding value β€’β€’β€’β€’ Premium profile

About Kumar Akshay Verma

Data last updated:

Kumar Akshay Verma is an Additional Director at Sezamo Biomedicare Private Limited (since 2019). The company operates in Veterinary.

DIN 08536483
Primary Designation Additional Director
Industry Veterinary
First Appointment 01 Aug 2019
Oldest Company Age 8 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Sezamo Biomedicare Private Limited U85200BR2018PTC038487
Additional Director01 Aug 20192018Active

Board colleagues of Kumar Akshay Verma

Directorship timeline

Open interactive timeline →
Sezamo Biomedicare Private Limited
Premium access

Shareholding and investment profile for Kumar Akshay Verma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kumar Akshay Verma

Kumar Akshay Verma currently holds 1 directorship: Sezamo Biomedicare Private Limited (Additional Director, since 01 Aug 2019).

Kumar Akshay Verma was first appointed on 01 Aug 2019 as Additional Director at Sezamo Biomedicare Private Limited.

The current boards of Kumar Akshay Verma's companies include Chandra Bhushan (Sezamo Biomedicare Private Limited), Rajeev Ranjan (Sezamo Biomedicare Private Limited), Shri Nath Arya (Sezamo Biomedicare Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available